Scaling National Screening and Linkage to Care for Hepatitis B and C in Nigeria | Sponsor: Gilead Sciences

Scaling National Screening and Linkage to Care for Hepatitis B and C in Nigeria

Project Status: On-going across all target states
Sponsor: Gilead Sciences

CFID is working with partner patient groups and members of the World Hepatitis Alliance (WHA) in respective target states and ministries of health to achieve the following goals of the project:

  • To identify and screen 6000 pregnant women for HBsAg and Anti-HCV and enroll all HBsAg and HBeAg positive into HBV care to improve Prevention of Mother to Child Transmission of Hepatitis B in Nigeria, before the end of project cycle in 2022.
  • To screen 3000 health care workers, and 5000 general populations including key populations for HBsAg and Anti-HCV and provide HBV vaccines to 50% of key populations screened negative to HBsAg and enroll into care all patients reactive to HBV and HCV before the end of project cycle in 2022
  • To train 1200 multidisciplinary health care workers to improve their skills on HBV and HCV management towards improving cascade of care and task-shifting at decentralized health facilities, before the end of project cycle in 2022

Target states for the project are:

  • Abuja FCT
  • Nasarawa
  • Kano
  • Enugu
  • Akwa-Ibom
  • Bauchi
  • Taraba

In each state, screening and linkage to care are being provided in line with best practices and acceptable standards. Project activities are ongoing.

About Administrator

Check Also

REPORT ON WORLD ANTIMICROBIAL AWARENESS WEEK (WAAW) 2021, IN TARABA ORGANIZED BY CENTRE FOR INITIATIVE AND DEVELOPMENT (CFID), TARABA

Theme: Spread Awareness, Stop Resistance. CFID Theme: The Role of Patients and Community Voice in …

Leave a Reply

Your email address will not be published.